The article profiles Anthony Atala, director of the Wake Forest Institute for Regenerative Medicine. He was part of a group, which reported the first human trial of tissue-engineered bladders in seven young spina bifida patients. He became interested in tissue engineering to improve surgical outcomes and address the shortages of donor organs during a fellowship at Children's Hospital Boston and Harvard Medical School.